[TABLE OF CONTENTS]

1 INTRODUCTION OF GLOBAL MEDICAL SIMULATION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY: MEDICAL SIMULATION MARKET

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS

4 GLOBAL MEDICAL SIMULATION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE

5 GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT AND SERVICES
5.1 OVERVIEW
5.2 ANATOMICAL MODELS
5.2.1 PATIENT SIMULATORS
5.2.1.1 HIGH-FIDELITY SIMULATORS
5.2.1.2 MEDIUM-FIDELITY SIMULATORS
5.2.1.3 LOW-FIDELITY SIMULATORS
5.2.2 TASK TRAINERS
5.2.3 INTERVENTIONAL/SURGICAL SIMULATORS
5.2.3.1 LAPAROSCOPIC SURGICAL SIMULATORS
5.2.3.2 GYNAECOLOGY SURGICAL SIMULATORS
5.2.3.3 CARDIAC SURGICAL SIMULATORS
5.2.3.5 ARTHROSCOPIC SURGICAL SIMULATORS
5.2.3.6 OTHER INTERVENTIONAL/SURGICAL SIMULATORS
5.2.4 ENDOVASCULAR SIMULATORS
5.2.5 ULTRASOUND SIMULATORS
5.2.6 DENTAL SIMULATORS
5.2.7 EYE SIMULATORS
5.3 WEB-BASED SIMULATION
5.4 MEDICAL SIMULATION SOFTWARE
5.4.1 PERFORMANCE RECORDING SOFTWARE
5.4.2 VIRTUAL TUTORS
5.5 SIMULATION TRAINING SERVICES
5.5.1 VENDOR-BASED TRAINING
5.5.2 EDUCATIONAL SOCIETIES
5.5.3 CUSTOM CONSULTING AND TRAINING SERVICES

6 GLOBAL MEDICAL SIMULATION MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 VIRTUAL PATIENT SIMULATION
6.3 3D PRINTING
6.4 PROCEDURE REHEARSAL TECHNOLOGY

7 GLOBAL MEDICAL SIMULATION MARKET, BY END-USE
7.1 OVERVIEW
7.2 ACADEMIC INSTITUTES
7.3 HOSPITALS
7.4 MILITARY ORGANIZATIONS
7.5 RESEARCH
7.5.1 MEDICAL DEVICE COMPANIES
7.5.2 OTHERS

8 GLOBAL MEDICAL SIMULATION MARKET, BY GEOGRAPHY
8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO

8.3 EUROPE

8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE

8.4 ASIA PACIFIC

8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA

8.6 SOUTH AMERICA

8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA

9 GLOBAL MEDICAL SIMULATION MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES

10 COMPANY PROFILES

10.1 CAE HEALTHCARE INC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.2 SIMULAB CORPORATION
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.3 3D SYSTEMS, INC
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.4 CARDIONICS
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.5 SIMULAIDS
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.6 MENTICE
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.7 LAERDAL MEDICAL
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.8 KYOTO KAGAKU CO LTD
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.9 GAUMARD SCIENTIFIC
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.10 INTELLIGENT ULTRASOUND (MEDAPHOR LTD.)
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.11 LIMBS & THINGS LTD
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS